Why is York Space Systems stock sliding today?
York Space Systems (YSS) shares fell about 9% to a new 52-week low near $13.65, last around $13.94, amid a Raymond James downgrade on July 29. The firm cut its rating to Market Perform, removed its $45 target, and lowered 2027-2028 revenue estimates. BlackRock sold over 204,000 shares; Q2 earnings are due Aug 13.
How this was made
The 30-second read
Why it matters
Traders may treat the downgrade and estimate cuts as the dominant near-term driver, using Aug. 13 earnings as the next catalyst to reassess revenue timing and expectations.
Market read
Company-specific negative catalysts are driving the move, not broad macro weakness.
What to watch
The article does not quantify backlog, contract awards, or margin trends, which could offset the procurement-timing narrative if Q2 results surprise.
Background
The piece attributes YSS weakness to an analyst downgrade, institutional selling, and downward EPS estimate revisions ahead of its Aug. 13 Q2 release.
Ticker impact
York Space Systems is down nearly 9% after a Raymond James downgrade to Market Perform and removal of its $45 price target.
Bearish near-term bias, with volatility elevated into the Q2 earnings date.
The article cites a specific downgrade (July 29), explicit estimate cuts tied to Space Force procurement timing, and an institutional sale by BlackRock, all reinforcing a negative setup ahead of earnings.
Market effects
Reinforces skepticism toward space and defense prime contractors tied to government procurement timing and revenue recognition delays.
No specific regional spillover beyond US-listed equities.
Limited, as the catalysts described are company-specific and US procurement related.
Counterpoint
The stock is already at a new 52-week low, so further downside may be partially priced in ahead of earnings.
Key entities
- companyYork Space Systems
US space and defense prime contractor whose shares are sliding toward a new 52-week low ahead of Q2 earnings.
- analyst_firmRaymond James
Downgraded YSS to Market Perform on July 29, removed its $45 price target, and cut 2027-2028 revenue estimates.
- institutional_investorBlackRock Portfolio Management LLC
Disclosed sale of over 204,000 YSS shares at end of July.


